Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DE:328
Stock Latest News
Ratings
MeiraGTx: Promising Gene Therapy Platform but Early-Stage Risks Keep Risk/Reward Balanced at Hold
10d ago
MGTX
Premium
The Fly
MeiraGTx initiated with a Neutral at Goldman Sachs
11d ago
MGTX
Premium
Company Announcements
MeiraGTx Appoints Veteran Investor Alan Sebulsky to Board
12d ago
8K
MGTX
Premium
The Fly
MeiraGTx appoints Sebulsky to its Board of Directors
12d ago
MGTX
Premium
The Fly
MeiraGTx reports Q2 EPS $1.71, consensus (42c)
2M ago
MGTX
Premium
Ratings
Mitchell Kapoor Reiterates Buy on MeiraGTx, Maintains $20 12-Month Price Target on Clinical Progress and Strengthened Balance Sheet
2M ago
MGTX
Premium
The Fly
MeiraGTx price target raised to $26 from $25 at RBC Capital
3M ago
MGTX
Premium
Ratings
Alec Stranahan Reaffirms Buy on MeiraGTx as Oberland Financing Strengthens Balance Sheet and Upcoming AQUAx2 and Bota-Vec Catalysts Support Upside
3M ago
MGTX
Premium
Company Announcements
MeiraGTx Secures Major Royalty Financing and Restructures Debt
3M ago
8K
MGTX
Premium
The Fly
MeiraGTx announces $400M investment by Oberland Capital
3M ago
MGTX
Premium
Company Announcements
MeiraGTx Shareholders Back Board Slate and Auditor Renewal
4M ago
8K
MGTX
Premium
The Fly
Acting FDA head vows to block political interference, Endpoint News says
4M ago
AZN
BMY
Premium
The Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
4M ago
AZN
BMY
Premium
Ratings
MeiraGTx: Buy Rating Reiterated as Pivotal AQUAx2 Path and Dual Launch Opportunities Support Unchanged $20 Price Target
4M ago
MGTX
Premium
The Fly
MeiraGTx reports Q1 EPS (57c), consensus (45c)
5M ago
MGTX
Premium
The Fly
FDA Commissioner Marty Makary resigns
5M ago
AZN
BMY
Premium
The Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
5M ago
AZN
BMY
Premium
The Fly
Trump Trade: U.S. plans AI security order without required model tests
5M ago
DYN
RNA
Premium
The Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
5M ago
DYN
RNA
Premium
Company Announcements
MeiraGTx Forms Strategic Gene Therapy Collaboration with Hologen
5M ago
8K
MGTX
Premium
The Fly
MeiraGTx price target raised to $30 from $26 at Piper Sandler
6M ago
JNJ
MGTX
Premium
The Fly
MeiraGTx price target raised to $24 from $16 at RBC Capital
6M ago
MGTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
